ZyVersa Therapeutics Changes Certifying Accountant
Ticker: ZVSA · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1859007
| Field | Detail |
|---|---|
| Company | Zyversa Therapeutics, Inc. (ZVSA) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, corporate-governance
TL;DR
ZyVersa swapped accountants on 4/4/25. New firm TBD.
AI Summary
ZyVersa Therapeutics, Inc. filed an 8-K on April 7, 2025, reporting changes in its certifying accountant. The filing indicates a change in the company's independent registered public accounting firm, with the new firm not yet specified. This change was effective as of April 4, 2025.
Why It Matters
A change in a company's auditor can sometimes signal underlying issues or a strategic shift, potentially impacting investor confidence and future financial reporting.
Risk Assessment
Risk Level: medium — Changes in auditors can sometimes precede or coincide with financial irregularities or significant business changes, warranting closer scrutiny.
Key Players & Entities
- ZyVersa Therapeutics, Inc. (company) — Registrant
- April 4, 2025 (date) — Effective date of change in accountant
- April 7, 2025 (date) — Filing date of the 8-K
FAQ
What is the name of the new certifying accountant for ZyVersa Therapeutics, Inc.?
The filing does not specify the name of the new certifying accountant.
When was the change in certifying accountant effective?
The change in certifying accountant was effective as of April 4, 2025.
What is the primary reason for the change in certifying accountant?
The filing states that the change is due to 'Changes in Registrant's Certifying Accountant' but does not provide specific details on the reason.
Was there any disagreement with the former certifying accountant?
The filing does not mention any disagreements with the former certifying accountant.
What is ZyVersa Therapeutics, Inc.'s principal executive office address?
ZyVersa Therapeutics, Inc.'s principal executive office is located at 2200 N. Commerce Parkway, Suite 208, Weston, Florida 33326.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding ZyVersa Therapeutics, Inc. (ZVSA).